{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:24:30Z","timestamp":1786951470610,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jdcr.2026.05.051","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:06:32Z","timestamp":1779865592000},"page":"165-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Delgocitinib cream for the treatment of refractory vulvar lichen sclerosus"],"prefix":"10.1016","volume":"74","author":[{"given":"Paige L.","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Preda-Naumescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-8308","authenticated-orcid":false,"given":"Christopher G.","family":"Bunick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jdcr.2026.05.051_bib1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.05.051_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.16241","article-title":"British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018","volume":"178","author":"Lewis","year":"2018","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2026.05.051_bib3","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/jdv.20082","article-title":"EuroGuiDerm guideline on lichen sclerosus\u2014introduction into lichen sclerosus","volume":"38","author":"Kirtschig","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdcr.2026.05.051_bib4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/bcp.70042","article-title":"Janus kinase inhibitors for the treatment of lichen sclerosus: a systematic review","volume":"91","author":"Shen","year":"2025","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.05.051_bib5","article-title":"The impact of genital lichen sclerosus and lichen planus on quality of life: a review","volume":"8","author":"Ranum","year":"2022","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.05.051_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/ajd.14172","article-title":"Baricitinib treatment of extragenital lichen sclerosus caused by COVID-19 vaccine","volume":"64","author":"Wang","year":"2023","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.05.051_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/bjd\/ljad129","article-title":"Abrocitinib as a novel treatment for lichen sclerosus","volume":"189","author":"Bao","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2026.05.051_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdcr.2024.02.010","article-title":"Treatment of plasma cell balanitis associated with male genital lichen sclerosus using abrocitinib","volume":"46","author":"Xiong","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"12","key":"10.1016\/j.jdcr.2026.05.051_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15942","article-title":"Bullous lichen sclerosus\u2013generalized morphea overlap syndrome improved by tofacitinib","volume":"35","author":"Liu","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdcr.2026.05.051_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdcr.2023.07.031","article-title":"Generalized extragenital lichen sclerosus et atrophicus in skin of color","volume":"40","author":"Jiang","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jdcr.2026.05.051_bib11","first-page":"188","article-title":"Novel clinical applications of topical ruxolitinib: a case series","volume":"23","author":"Zundell","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdcr.2026.05.051_bib12","first-page":"101","article-title":"Treatment satisfaction, efficacy, and safety of delgocitinib ointment following switch from topical corticosteroids for trunk and extremity rash in atopic dermatitis","volume":"53","author":"Kobayashi","year":"2025","journal-title":"JAAD Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626003255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626003255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:37:07Z","timestamp":1786948627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626003255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":12,"alternative-id":["S2352512626003255"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.05.051","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delgocitinib cream for the treatment of refractory vulvar lichen sclerosus","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}